{"gene":"PAX9","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1998,"finding":"Pax9-deficient mice arrest tooth development at the bud stage and show loss of mesenchymal expression of Bmp4, Msx1, and Lef1, establishing Pax9 as required for the inductive capacity of the tooth mesenchyme.","method":"Targeted gene knockout (null allele) in mice; in situ hybridization for downstream markers","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype and downstream marker analysis, replicated across multiple subsequent studies","pmids":["9732271"],"is_preprint":false},{"year":1995,"finding":"PAX9 protein binds to the e5 paired-domain recognition sequence from the Drosophila even-skipped promoter, demonstrating DNA-binding activity shared with PAX1.","method":"In vitro DNA-binding assay (gel shift / EMSA) with the e5 sequence","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro binding assay, single lab, single method","pmids":["7649395"],"is_preprint":false},{"year":1999,"finding":"Pax1 and Pax9 act redundantly to control vertebral column development: double homozygous mutant mice completely lack vertebral bodies, intervertebral discs and proximal ribs, with reduced cell proliferation in ventromedial sclerotomes and subsequent increased apoptosis; single Pax9 homozygous mutants show no axial defect, while Pax9 is spatially upregulated to compensate for Pax1 loss.","method":"Genetic epistasis using Pax1/Pax9 compound mutant mice; histology, BrdU proliferation assay, TUNEL apoptosis assay, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-mutant epistasis with multiple orthogonal readouts, replicated by subsequent studies","pmids":["10556064"],"is_preprint":false},{"year":2003,"finding":"Pax1 and Pax9 directly activate the Bapx1 promoter and physically interact with Bapx1 regulatory sequences; overexpression of Pax1 in chick presomitic mesoderm can substitute for Shh in inducing Bapx1 and initiating chondrogenic differentiation, establishing Bapx1 as a direct transcriptional target of Pax1/Pax9 downstream of Shh in sclerotome development.","method":"Pax1/Pax9 double-mutant analysis; retroviral Pax1 overexpression in chick explants; promoter-binding (transactivation assays and direct interaction with Bapx1 promoter region)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — transactivation assay + promoter binding + gain-of-function in explants, single lab with multiple orthogonal methods","pmids":["12490554"],"is_preprint":false},{"year":2006,"finding":"PAX9 directly regulates Msx1 expression; PAX9 and MSX1 proteins physically interact and synergistically transactivate the Msx1 and Bmp4 promoters. A paired-domain missense mutation (L21P/T62C) abolishes DNA binding and promoter transactivation but retains protein-protein interaction with MSX1, indicating PAX9 regulates Bmp4 through its DNA-binding paired domain rather than solely through MSX1 protein interaction.","method":"Co-immunoprecipitation; luciferase reporter/transactivation assays with wild-type and mutant PAX9; DNA-binding assays (EMSA)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (co-IP, EMSA, reporter assay, mutagenesis) in a single rigorous study","pmids":["16651263"],"is_preprint":false},{"year":2005,"finding":"Pax9 and MSX1 proteins physically associate in vitro and in vivo (Co-IP and GST pull-down), consistent with a functional protein-protein interaction during tooth development.","method":"Co-immunoprecipitation and GST pull-down interaction assays","journal":"Archives of oral biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reciprocal Co-IP and GST pulldown, single lab","pmids":["15721141"],"is_preprint":false},{"year":2003,"finding":"The 219InsG frameshift mutation in the PAX9 paired domain produces a protein with abolished DNA binding to e5 and CD19-2(A-ins) sequences and no transcriptional activation from paired-domain binding sites; the mutant protein also shows altered nuclear localization. Wild-type PAX9 transactivation is not impaired by co-expression of the mutant, indicating loss-of-function rather than dominant-negative mechanism.","method":"EMSA (gel mobility shift), co-transfection reporter assay, immunofluorescence localization, dominant-negative test in co-transfection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (EMSA, reporter, localization, dominant-negative test) in a single study","pmids":["14607846"],"is_preprint":false},{"year":2003,"finding":"PLU-1 interacts with PAX9 (and BF-1) via a conserved VP motif; PAX9 represses transcription in reporter assays, and co-expression of PLU-1 with PAX9 significantly enhances this repression. Deletion or site-directed mutagenesis of the VP motif in PAX9 abolishes PLU-1 co-repressor activity, identifying PLU-1 as a transcriptional co-repressor of PAX9.","method":"Yeast two-hybrid screen; site-directed mutagenesis of VP motif; reporter (transcriptional repression) assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus mutagenesis plus reporter assay, single lab with multiple orthogonal methods","pmids":["12657635"],"is_preprint":false},{"year":2003,"finding":"The R28P missense mutation in the N-terminal subdomain of the PAX9 paired domain dramatically reduces DNA binding to double-stranded paired-domain recognition sequences in vitro, supporting loss of DNA binding as the pathogenic mechanism for oligodontia.","method":"Gel mobility shift assay (EMSA) comparing wild-type and R28P mutant PAX9 paired domain binding to dsDNA targets","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro EMSA, single lab, single method","pmids":["14689302"],"is_preprint":false},{"year":2006,"finding":"The Ile87Phe mutation in the C-terminal subdomain of the PAX9 paired domain abolishes DNA binding to e5 and CD19-2(A-ins) sequences but does not alter nuclear localization or protein-protein interaction with MSX1, demonstrating that DNA binding is selectively disrupted independent of partner protein interaction or trafficking.","method":"Gel shift assay (EMSA); cell fractionation/immunolocalization; co-immunoprecipitation with MSX1","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — EMSA + co-IP + localization, single lab","pmids":["16479262"],"is_preprint":false},{"year":2009,"finding":"Structural and functional analysis of eight paired-domain missense mutations in PAX9 shows that most reduce DNA binding and transactivation of Bmp4 and Msx1 promoters correlating with disease severity; all mutants retain nuclear localization and physical interaction with MSX1; one mutant (retaining DNA binding) shows a dominant-negative effect and loss of synergism with MSX1 rather than loss of DNA binding.","method":"Subcellular localization (immunofluorescence), co-immunoprecipitation with MSX1, EMSA, luciferase reporter assays, structure-based modeling","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods across 8 mutations, single lab","pmids":["19429910"],"is_preprint":false},{"year":1996,"finding":"Zebrafish Pax9 produces two splice isoforms (Pax9a and Pax9b) with distinct C-terminal transactivating domains of different potency; both activate transcription from a paired-domain binding site at low expression levels but show dose-dependent repression at higher amounts. The N-terminal region (including the paired domain) negatively regulates the C-terminal transactivation domains.","method":"Alternative splicing characterization; transactivation reporter assays with Pax9a and Pax9b expression vectors; paired-domain binding-site specificity assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — reporter assay + splicing analysis, single lab","pmids":["8900176"],"is_preprint":false},{"year":2000,"finding":"Genetic epistasis in Uncx4.1 mutant mice shows loss of pedicles and proximal ribs resembling the Pax1/Pax9 double-mutant phenotype, placing Uncx4.1 upstream of Pax9 in the caudolateral sclerotome developmental pathway.","method":"Targeted Uncx4.1 knockout mouse; comparison of skeletal phenotype with Pax1/Pax9 double mutants; histological and marker analysis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis by phenotypic comparison, single lab","pmids":["10804168"],"is_preprint":false},{"year":2005,"finding":"Reduction of Pax9 gene dosage (hypomorphic and null allelic series in mice) causes oligodontia: homozygous hypomorphic mice show missing lower incisors and third molars, while compound hypomorphic/null mice develop severe oligodontia with dental arrest at different stages. Continuously growing incisors also exhibit enamel defects, establishing that a minimum Pax9 dosage is required throughout tooth development.","method":"Hypomorphic allele (Pax9neo) generation; compound allele analysis; histology of teeth at different developmental stages","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — allelic series with graded dosage effects, multiple tooth types and stages analyzed, single lab","pmids":["16236760"],"is_preprint":false},{"year":2010,"finding":"Pax9 and Msx1 interact genetically in vivo: double homozygous mutants exhibit cleft lip; double heterozygous mutants consistently lack lower incisors with reduced Shh/Bmp2 expression defining a smaller incisor field, drastically reduced Fgf3/Fgf10 mesenchymal expression, reduced cell proliferation, and abnormal ameloblast differentiation. Transgenic BMP4 partially rescues the double-heterozygous incisor phenotype.","method":"Compound Pax9/Msx1 mutant mice; in situ hybridization for Shh, Bmp2, Fgf3, Fgf10, Notch1; BrdU proliferation assay; BMP4 transgenic rescue","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — compound mutant genetic epistasis with multiple orthogonal readouts and transgenic rescue, single lab","pmids":["20123092"],"is_preprint":false},{"year":2011,"finding":"Osr2 acts downstream of Pax9 during tooth development: Osr2 mRNA is downregulated in Pax9-deficient tooth mesenchyme; Osr2 expression from the Pax9 locus (knock-in) rescues supernumerary tooth formation in Osr2-/- mutants; Osr2 forms a stable protein complex with MSX1 and interacts weakly with PAX9 in co-transfected cells.","method":"Pax9-conditional knockout with Osr2 knock-in (Pax9Osr2KI); co-immunoprecipitation of Osr2 with MSX1 and PAX9; in situ hybridization for Osr2, Bmp4, Msx1","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (knock-in rescue) plus co-IP protein interactions, single lab with multiple orthogonal methods","pmids":["21420399"],"is_preprint":false},{"year":2013,"finding":"Pax9 regulates palate development by controlling a molecular network: conditional deletion of Pax9 in palatal mesenchyme reduces Bmp4, Fgf10, Msx1, and Osr2 expression and disrupts Shh in palatal epithelium. Restoration of Osr2 expression from the Pax9 locus (Pax9Osr2KI knock-in) rescues posterior palate morphogenesis in the absence of Pax9 function, placing Osr2 downstream of Pax9 in this pathway.","method":"Tissue-specific Pax9 conditional knockout; Pax9Osr2KI knock-in rescue; in situ hybridization for Bmp4, Fgf10, Msx1, Osr2, Shh","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO plus knock-in rescue plus multiple downstream marker analysis, single lab with multiple orthogonal methods","pmids":["24173808"],"is_preprint":false},{"year":2017,"finding":"Pax9 regulates Wnt signaling during palatogenesis by suppressing expression of Dkk1 and Dkk2 (Wnt antagonists); ChIP-qPCR shows Pax9 directly binds to regions near the transcription start sites of Dkk1 and Dkk2 and to the intergenic region of Wnt9b/Wnt3. Genetic reduction of Dkk1 (or pharmacological Dkk inhibition) rescues secondary palate clefts in Pax9-/- mice, and genetic overexpression of Dkk1 phenocopies Pax9-/- palate and tooth defects.","method":"Genetic Dkk1 reduction/overexpression; small-molecule Dkk inhibitor delivery in utero; ChIP-qPCR for Pax9 binding to Dkk1, Dkk2, Wnt9b/Wnt3 loci","journal":"Development (Cambridge, England) / Developmental dynamics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — ChIP-qPCR binding + genetic rescue + pharmacological rescue, single lab with multiple orthogonal methods","pmids":["28893947","32390226"],"is_preprint":false},{"year":2017,"finding":"Pax9-deficient mice show reduced canonical Wnt signaling in developing palatal mesenchyme (reduced Axin2, reduced active β-catenin, increased Dkk2); genetic inactivation of Wise (a secreted Wnt antagonist expressed in palatal shelves) in Pax9-deficient embryos rescues palatal shelf elevation/reorientation and restores hyaluronic acid accumulation, placing canonical Wnt signaling downstream of Pax9 in palate elevation.","method":"Pax9/Wise double-mutant genetic epistasis; immunohistochemistry for active β-catenin, Axin2, hyaluronic acid; in situ hybridization for Dkk2","journal":"Journal of dental research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — double-mutant genetic rescue with multiple molecular readouts, single lab","pmids":["28692808"],"is_preprint":false},{"year":2017,"finding":"Pax9 is required for normal squamous cell differentiation in the oro-oesophageal epithelium: Pax9 deficiency in mouse oesophagus promotes cell proliferation and delays differentiation; ethanol exposure downregulates PAX9 in human oesophageal epithelial cells and mouse forestomach/tongue. PAX9 promoter hypermethylation is associated with silencing in human oro-oesophageal squamous cell carcinoma. PAX9 deficiency or ethanol promotes carcinogen-induced squamous cell carcinogenesis in mice.","method":"Conditional Pax9 knockout in mouse oesophagus; global gene expression profiling; ethanol exposure in vitro and in vivo; bisulfite sequencing for promoter methylation; carcinogen (NMBA) challenge model","journal":"The Journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO phenotype + methylation + carcinogenesis model, single lab with multiple methods","pmids":["29055049"],"is_preprint":false},{"year":2002,"finding":"Pax9 is required in thymic epithelial cells for normal thymopoiesis: in Pax9 null mice, the thymic anlage forms as an ectopic polyp-like structure in the larynx expressing Foxn1/Whn, fails to migrate to the upper mediastinum, and is severely reduced in size by E14.5; TCRβ expression is detectable but TCRγ is absent.","method":"Pax9 null mouse analysis; immunohistochemistry and marker expression (Whn/Foxn1, TCRβ, TCRγ)","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean KO with defined cellular phenotype, single lab, single genetic model","pmids":["11932925"],"is_preprint":false},{"year":2004,"finding":"Pax9 regulates region-specific differentiation of the tongue epithelium: in Pax9-deficient mice, filiform papillae lack anterior-posterior polarity (associated with altered Hoxc13 expression), barrier formation is disturbed, 'hard' keratins (Krt1-5, Krt1-24, Krt2-16) are not expressed, and 'soft' skin-specific keratins are upregulated, indicating partial trans-differentiation of tongue epithelium toward skin.","method":"Pax9 null mouse; genome-wide expression profiling; in situ hybridization for keratins and Hoxc13","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with genome-wide profiling and specific marker validation, single lab","pmids":["15454262"],"is_preprint":false},{"year":2005,"finding":"Pax9 expression in the anterior limb mesenchyme is dependent on Gli3 (repressor function) and is regulated by Shh-mediated Gli3 processing in a context-dependent manner: in Gli3Xt/Xt polydactylous mice, Pax9 is downregulated in anterior limb; Shh bead implantation in chick shows context-dependent Pax9 regulation differing between limb and somite.","method":"Gli3 null (Extra-toes) mouse transcriptional analysis; Shh/Gli3 compound mutant; Shh bead implantation in chick limb and somite","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic models and in vivo Shh signaling assay, single lab","pmids":["16169709"],"is_preprint":false},{"year":2014,"finding":"Pax9 acts upstream of Pax1 and Sox9 in the expanding taste progenitor field of the circumvallate papilla; Pax9-deficient mice completely fail to develop circumvallate papilla (arrest vs. partial reduction in Pax1 mutants). Pax9 is also required for Pax9-dependent induction of taste placodes in the soft palate but is dispensable for fungiform papilla taste bud development. Loss of Pax9 causes circumvallate taste progenitor cells to lack K8 and Prox1 expression and to differentiate into epidermal-like epithelium.","method":"Pax9 and Pax1 null mouse phenotypic comparison; genetic epistasis; immunofluorescence for K8, Prox1; in situ hybridization","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple orthogonal marker readouts, single lab","pmids":["25299669"],"is_preprint":false},{"year":2014,"finding":"A G-quadruplex structure in PAX9 intron 1 (near exon 1) enhances splicing efficiency of PAX9 intron 1: mutation abolishing quadruplex formation dramatically decreases splicing efficiency in a reporter assay, and stabilization with the G-quadruplex ligand 360A further increases splicing efficiency.","method":"Circular dichroism (CD) spectroscopy; double-reporter splicing assay; qPCR; pharmacological G-quadruplex stabilization","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — biophysical structure confirmation + functional splicing assay + pharmacological validation, single lab","pmids":["25204874"],"is_preprint":false},{"year":2019,"finding":"Pax9 is required in the pharyngeal endoderm for cardiovascular development; Pax9-deficient mice are born with complex cardiovascular malformations affecting the outflow tract and aortic arch arteries. Pax9 and Tbx1 genetically interact in the pharyngeal endoderm: double Tbx1+/-;Pax9+/- heterozygotes have significantly increased interrupted aortic arch incidence compared with Tbx1+/- alone. A Pax9Cre allele localizes the Tbx1-Pax9 interaction site to pharyngeal endoderm.","method":"Pax9 null mouse cardiovascular phenotyping; Tbx1/Pax9 double heterozygous mouse; Pax9Cre lineage tracing; transcriptome analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO phenotype + double-heterozygous epistasis + Cre-localization of interaction site, single lab with multiple orthogonal methods","pmids":["31444215"],"is_preprint":false},{"year":2008,"finding":"Pbx1/Pbx2 control Pax1/Pax9 expression in the sclerotome; in Pbx1/Pbx2 compound mutant mice, Pax1/Pax9 expression is downregulated in the sclerotome, and axial skeletal development is severely disrupted, placing Pbx1/Pbx2 genetically upstream of Pax1/Pax9 in the sclerotomal pathway.","method":"Pbx1/Pbx2 compound mutant mouse; marker analysis by in situ hybridization for Pax1, Pax9; skeletal phenotyping","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — compound mutant epistasis, single lab","pmids":["18691704"],"is_preprint":false},{"year":2017,"finding":"PAX9 overexpression in dental pulp cells upregulates LEF1 and AXIN2 expression, indicating a positive regulatory role for PAX9 in canonical Wnt signaling; PAX9 missense mutations show differential loss of transcriptional activity and all overexpressed mutants except Pro118Ser show proper nuclear localization.","method":"PAX9 overexpression in dental pulp cells; RT-qPCR for LEF1 and AXIN2; immunofluorescence for subcellular localization; luciferase reporter assay","journal":"Annals of the New York Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — overexpression + reporter assay + localization, single lab","pmids":["37005710"],"is_preprint":false},{"year":2021,"finding":"PAX9 occupies distal enhancer elements genome-wide in SCLC cells and represses nearby gene expression by restricting enhancer activity; PAX9 physically interacts and cofunctions with the NuRD (nucleosome remodeling and deacetylase) complex at enhancers. Genetic depletion of PAX9 induces a primed-to-active enhancer transition and upregulates neural differentiation and tumor-suppressive genes; pharmacological HDAC inhibition reverses PAX9/NuRD-mediated repression.","method":"Genome-wide CRISPR-Cas9 dropout screen; ChIP-seq for PAX9 occupancy; genome-wide enhancer state analysis (H3K4me1, H3K27ac); co-immunoprecipitation of PAX9 with NuRD complex; HDAC inhibitor treatment; RNA-seq after PAX9 depletion","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — genome-wide ChIP-seq + co-IP + CRISPR KO + pharmacological rescue, single lab with multiple orthogonal methods","pmids":["34341073"],"is_preprint":false},{"year":2019,"finding":"SIX2 directly binds a PAX9 5' upstream regulatory element and activates PAX9 expression; a human SIX2 coding variant (p.Gly264Glu) found in a cleft palate patient destabilizes SIX2 protein and reduces PAX9 expression, placing SIX2 upstream of PAX9 in the palatogenesis regulatory network.","method":"SIX2 null mouse (22% cleft palate penetrance); ChIP/binding to PAX9 regulatory element; functional analysis of SIX2 p.Gly264Glu variant on PAX9 expression","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO phenotype + direct binding assay + human variant functional validation, single lab","pmids":["31765609"],"is_preprint":false},{"year":2008,"finding":"Pax9 and c-myb function in the same pathway in oral squamous carcinoma cells: Pax9 knockdown induces apoptosis (caspase-3/PARP cleavage, increased Bax, decreased Bcl-2); c-myb overexpression upregulates Pax9; dominant-negative c-myb downregulates Pax9 without Pax9 affecting c-myb levels, placing c-myb upstream of Pax9 in cell survival regulation. Both Pax9 knockdown and dominant-negative c-myb arrest the cell cycle at G0.","method":"Pax9 siRNA knockdown; adenoviral c-myb overexpression and dominant-negative c-myb; flow cytometry (cell cycle); Western blot for caspase-3, PARP, Bax, Bcl-2","journal":"Cell biochemistry and function","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — siRNA KD + OE with multiple readouts, single lab","pmids":["18979497"],"is_preprint":false}],"current_model":"PAX9 is a paired-domain transcription factor that directly binds DNA recognition sequences and activates/represses target gene promoters (including Bmp4, Msx1, Lef1, Bapx1, Dkk1, Dkk2); it physically interacts with MSX1, OSR2, and PLU-1/NuRD complex to regulate transcription, acts upstream of Wnt (Dkk1/2 suppression), BMP, FGF, and SHH signaling cascades, and is essential—in a dose-dependent manner—for tooth morphogenesis (bud-to-cap transition), palatogenesis (mesenchyme-epithelium signaling via Osr2/Fgf10/Bmp4/Wnt), vertebral column chondrogenesis (redundantly with Pax1 through Bapx1), pharyngeal pouch organ (thymus, parathyroid) development, cardiovascular arch artery morphogenesis (via pharyngeal endoderm Tbx1 interaction), tongue epithelial differentiation, and circumvallate taste bud progenitor expansion."},"narrative":{"mechanistic_narrative":"PAX9 is a paired-domain transcription factor that directs reciprocal mesenchymal-epithelial signaling during the development of teeth, palate, axial skeleton, pharyngeal organs, and taste-bearing epithelia [PMID:9732271, PMID:10556064]. Through its paired domain it binds defined recognition sequences (e.g., the e5 site) and transactivates target promoters, with disease-associated missense and frameshift mutations selectively abolishing DNA binding and transactivation of Bmp4 and Msx1 while sparing nuclear localization and protein partner interaction, establishing loss of DNA binding as the predominant pathogenic mechanism in PAX9-associated oligodontia [PMID:7649395, PMID:14607846, PMID:19429910]. In tooth and palate mesenchyme PAX9 sustains an inductive program—activating Bmp4, Msx1, Fgf3/Fgf10, and Osr2—and acts in part by physically associating with and synergizing with MSX1 on the Msx1 and Bmp4 promoters [PMID:9732271, PMID:16651263, PMID:20123092, PMID:24173808]; Osr2 lies genetically downstream, as Osr2 knocked into the Pax9 locus rescues Pax9-dependent palate morphogenesis [PMID:21420399, PMID:24173808]. PAX9 also gates Wnt signaling during palatogenesis, directly binding and repressing the Wnt antagonists Dkk1 and Dkk2 so that reducing Dkk1 or Wise rescues Pax9-null palatal clefts [PMID:28893947, PMID:32390226, PMID:28692808]. In the axial skeleton PAX9 functions redundantly with PAX1 to drive sclerotome chondrogenesis through direct activation of the Bapx1 promoter downstream of Shh [PMID:10556064, PMID:12490554], and it is further required in pharyngeal endoderm for cardiovascular outflow morphogenesis via genetic interaction with Tbx1 [PMID:31444215] and for thymic epithelial development [PMID:11932925]. Beyond development, PAX9 can act as a context-dependent transcriptional repressor: it recruits the PLU-1/NuRD complex through a conserved VP motif [PMID:12657635] and occupies distal enhancers genome-wide in small-cell lung cancer cells to restrict enhancer activity and suppress differentiation genes [PMID:34341073].","teleology":[{"year":1995,"claim":"Established that PAX9 is a sequence-specific DNA-binding protein, defining the biochemical basis for its later-discovered transcriptional roles.","evidence":"In vitro EMSA with the Drosophila even-skipped e5 paired-domain recognition site","pmids":["7649395"],"confidence":"Medium","gaps":["No endogenous mammalian target identified at this stage","Activator vs. repressor function not resolved"]},{"year":1996,"claim":"Resolved that PAX9 transactivation is dose- and isoform-dependent, with the N-terminal/paired region negatively regulating C-terminal activation domains.","evidence":"Zebrafish Pax9a/Pax9b splice isoform reporter assays with paired-domain binding sites","pmids":["8900176"],"confidence":"Medium","gaps":["Functional relevance of dual isoforms in mammals unknown","Switch between activation and repression not mechanistically defined"]},{"year":1998,"claim":"Demonstrated that Pax9 is required for the inductive capacity of tooth mesenchyme, placing it at the top of an odontogenic signaling cascade.","evidence":"Pax9 null mouse with in situ analysis of Bmp4, Msx1, Lef1 at the tooth bud stage","pmids":["9732271"],"confidence":"High","gaps":["Whether Bmp4/Msx1/Lef1 are direct vs. indirect targets not shown","Cell-autonomous mechanism within mesenchyme not dissected"]},{"year":1999,"claim":"Revealed functional redundancy between Pax1 and Pax9 in vertebral column formation, explaining the absence of axial defects in single Pax9 mutants.","evidence":"Pax1/Pax9 compound mutant mice with histology, BrdU, TUNEL, in situ hybridization","pmids":["10556064"],"confidence":"High","gaps":["Shared vs. distinct downstream targets not defined here","Molecular basis of Pax9 compensatory upregulation unknown"]},{"year":2000,"claim":"Positioned Uncx4.1 upstream of Pax9 in the caudolateral sclerotome pathway, beginning to assemble the regulatory hierarchy controlling axial Pax9 expression.","evidence":"Uncx4.1 knockout mouse skeletal phenotype compared with Pax1/Pax9 double mutants","pmids":["10804168"],"confidence":"Medium","gaps":["Direct vs. indirect regulation of Pax9 not established","No biochemical link demonstrated"]},{"year":2003,"claim":"Identified Bapx1 as a direct Pax1/Pax9 transcriptional target downstream of Shh, connecting Pax9 to sclerotome chondrogenic differentiation.","evidence":"Promoter transactivation/binding assays plus retroviral Pax1 gain-of-function in chick presomitic mesoderm","pmids":["12490554"],"confidence":"High","gaps":["Direct Pax9 (vs. Pax1) binding to Bapx1 not separately quantified","Cofactor requirements at the promoter not defined"]},{"year":2003,"claim":"Defined PLU-1 as a VP-motif-dependent co-repressor of PAX9, revealing that PAX9 can actively repress transcription.","evidence":"Yeast two-hybrid, VP-motif mutagenesis, and repression reporter assays","pmids":["12657635"],"confidence":"Medium","gaps":["Endogenous PAX9-repressed genes not identified","In vivo relevance of PLU-1 interaction untested"]},{"year":2003,"claim":"Established that oligodontia-causing PAX9 paired-domain mutations (219InsG, R28P) abolish DNA binding via loss-of-function rather than dominant-negative mechanism.","evidence":"EMSA, reporter assays, immunofluorescence localization, and co-transfection dominant-negative tests of mutant PAX9","pmids":["14607846","14689302"],"confidence":"High","gaps":["Genotype-phenotype severity correlation not yet mapped","Effect on partner protein function not assessed"]},{"year":2005,"claim":"Showed that a minimum Pax9 gene dosage is required throughout tooth development, linking quantitative Pax9 levels to graded oligodontia severity.","evidence":"Hypomorphic/null allelic series in mice with staged tooth histology","pmids":["16236760"],"confidence":"High","gaps":["Dosage-sensitive target genes not defined","Threshold mechanism at the molecular level unknown"]},{"year":2005,"claim":"Documented direct physical association of PAX9 with MSX1, providing a protein-interaction basis for combinatorial regulation in tooth development.","evidence":"Reciprocal Co-IP and GST pull-down assays","pmids":["15721141"],"confidence":"Medium","gaps":["Interaction interface not mapped","Functional consequence on transcription not tested in this study"]},{"year":2006,"claim":"Demonstrated that PAX9 and MSX1 synergistically transactivate Msx1 and Bmp4 promoters and that PAX9 regulates Bmp4 through its DNA-binding paired domain, separating DNA-binding from protein-interaction functions.","evidence":"Co-IP, EMSA, luciferase reporter assays with wild-type and DNA-binding-deficient mutant PAX9; analysis of the Ile87Phe mutation","pmids":["16651263","16479262"],"confidence":"High","gaps":["Stoichiometry and structure of the PAX9-MSX1-DNA complex unknown","Other partner-dependent target genes not identified"]},{"year":2009,"claim":"Correlated paired-domain mutation effects on DNA binding and transactivation with oligodontia severity and identified a rare dominant-negative mutant acting through loss of MSX1 synergy.","evidence":"Structure-based modeling, EMSA, reporter assays, Co-IP and localization across eight missense mutants","pmids":["19429910"],"confidence":"High","gaps":["High-resolution PAX9-DNA structure not solved","Mechanism of dominant-negative interference not fully defined"]},{"year":2010,"claim":"Established in vivo genetic interaction between Pax9 and Msx1 in incisor and lip development, with BMP4 acting downstream as a partial mediator.","evidence":"Compound Pax9/Msx1 mutant mice with marker in situ, BrdU assays, and BMP4 transgenic rescue","pmids":["20123092"],"confidence":"High","gaps":["Direct vs. indirect control of Fgf3/Fgf10 not resolved","Incomplete rescue indicates additional unidentified effectors"]},{"year":2011,"claim":"Placed Osr2 downstream of Pax9 in tooth development, with Osr2 knock-in rescuing supernumerary tooth phenotypes.","evidence":"Pax9-conditional knockout with Pax9-locus Osr2 knock-in; Co-IP of Osr2 with MSX1 and PAX9","pmids":["21420399"],"confidence":"High","gaps":["Whether Pax9 directly binds the Osr2 promoter not shown","Weak PAX9-Osr2 interaction functional role unclear"]},{"year":2013,"claim":"Defined Pax9 as the controller of a Bmp4/Fgf10/Msx1/Osr2/Shh network in palatal mesenchyme, with Osr2 sufficient to rescue posterior palate morphogenesis.","evidence":"Tissue-specific Pax9 conditional knockout and Pax9-locus Osr2 knock-in with downstream marker in situ hybridization","pmids":["24173808"],"confidence":"High","gaps":["Direct PAX9 binding to these promoters in palate not all demonstrated","Anterior vs. posterior palate mechanistic differences not fully resolved"]},{"year":2017,"claim":"Identified direct PAX9 repression of Wnt antagonists Dkk1/Dkk2 as the mechanism linking Pax9 to canonical Wnt signaling in palatogenesis, validated by genetic and pharmacological rescue.","evidence":"ChIP-qPCR for Pax9 at Dkk1/Dkk2/Wnt loci; genetic Dkk1 reduction/overexpression; in utero Dkk inhibitor; Pax9/Wise double-mutant rescue with β-catenin/Axin2 readouts","pmids":["28893947","32390226","28692808"],"confidence":"High","gaps":["Direct vs. indirect contribution of Wnt9b/Wnt3 binding unclear","Tissue-specific cofactors for repression not identified"]},{"year":2017,"claim":"Extended Pax9 function to squamous epithelial differentiation, showing it restrains proliferation and that its silencing (including by ethanol and promoter hypermethylation) promotes squamous carcinogenesis.","evidence":"Conditional Pax9 knockout in mouse oesophagus, expression profiling, ethanol exposure, bisulfite sequencing, NMBA carcinogen model","pmids":["29055049"],"confidence":"Medium","gaps":["Direct transcriptional targets in epithelium not defined","Mechanism connecting PAX9 loss to carcinogenesis incomplete"]},{"year":2019,"claim":"Demonstrated a pharyngeal-endoderm requirement for Pax9 in cardiovascular development through genetic interaction with Tbx1.","evidence":"Pax9 null cardiovascular phenotyping, Tbx1/Pax9 double-heterozygous epistasis, Pax9Cre lineage tracing, transcriptomics","pmids":["31444215"],"confidence":"High","gaps":["Direct biochemical Pax9-Tbx1 relationship not shown","Endodermal target genes mediating arch artery defects not identified"]},{"year":2019,"claim":"Positioned SIX2 as a direct upstream activator of PAX9 in palatogenesis, with a human SIX2 variant reducing PAX9 expression.","evidence":"SIX2 null mouse, ChIP/binding to PAX9 regulatory element, functional analysis of SIX2 p.Gly264Glu","pmids":["31765609"],"confidence":"Medium","gaps":["Other upstream regulators of PAX9 in palate not mapped","Quantitative contribution of SIX2 to PAX9 dosage unclear"]},{"year":2021,"claim":"Revealed a genome-wide enhancer-repression mechanism in which PAX9 cofunctions with the NuRD complex to restrict differentiation and tumor-suppressor gene activity in SCLC.","evidence":"CRISPR dropout screen, PAX9 ChIP-seq, enhancer-state profiling, PAX9-NuRD Co-IP, HDAC inhibitor rescue, RNA-seq after depletion","pmids":["34341073"],"confidence":"High","gaps":["DNA sequence determinants of enhancer occupancy not defined","Generalizability beyond SCLC unknown"]},{"year":null,"claim":"It remains unknown how PAX9 switches between activator and repressor modes across tissues and how cofactor choice (MSX1, OSR2, PLU-1/NuRD) is determined at specific loci.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of PAX9 bound to DNA with cofactors","Mechanism selecting activation vs. repression context not resolved","Full genome-wide target catalog in developmental tissues lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,4,6,8,9,10,28]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,4,7,11,17,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,9,10,27]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,2,16,23,25]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,17,28]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,17,18]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[28]}],"complexes":["NuRD complex"],"partners":["MSX1","OSR2","PLU-1","TBX1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P55771","full_name":"Paired box protein Pax-9","aliases":[],"length_aa":341,"mass_kda":36.3,"function":"Transcription factor required for normal development of thymus, parathyroid glands, ultimobranchial bodies, teeth, skeletal elements of skull and larynx as well as distal limbs","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P55771/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAX9","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PAX9","total_profiled":1310},"omim":[{"mim_id":"614940","title":"ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A","url":"https://www.omim.org/entry/614940"},{"mim_id":"613457","title":"CHROMOSOME 14q11-q22 DELETION SYNDROME","url":"https://www.omim.org/entry/613457"},{"mim_id":"611297","title":"ODD-SKIPPED-RELATED TRANSCRIPTION FACTOR 2; OSR2","url":"https://www.omim.org/entry/611297"},{"mim_id":"610978","title":"CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP","url":"https://www.omim.org/entry/610978"},{"mim_id":"608615","title":"OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS","url":"https://www.omim.org/entry/608615"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoli","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"esophagus","ntpm":76.7},{"tissue":"parathyroid gland","ntpm":40.5},{"tissue":"salivary gland","ntpm":48.8}],"url":"https://www.proteinatlas.org/search/PAX9"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P55771","domains":[{"cath_id":"1.10.10.10","chopping":"6-62","consensus_level":"high","plddt":96.9789,"start":6,"end":62},{"cath_id":"1.10.10.10","chopping":"76-120","consensus_level":"medium","plddt":93.304,"start":76,"end":120}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P55771","model_url":"https://alphafold.ebi.ac.uk/files/AF-P55771-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P55771-F1-predicted_aligned_error_v6.png","plddt_mean":63.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAX9","jax_strain_url":"https://www.jax.org/strain/search?query=PAX9"},"sequence":{"accession":"P55771","fasta_url":"https://rest.uniprot.org/uniprotkb/P55771.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P55771/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P55771"}},"corpus_meta":[{"pmid":"9732271","id":"PMC_9732271","title":"Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9732271","citation_count":638,"is_preprint":false},{"pmid":"7649395","id":"PMC_7649395","title":"Characterization and developmental expression of Pax9, a paired-box-containing gene related to Pax1.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7649395","citation_count":233,"is_preprint":false},{"pmid":"10556064","id":"PMC_10556064","title":"Pax1 and Pax9 synergistically regulate vertebral column development.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10556064","citation_count":205,"is_preprint":false},{"pmid":"7981748","id":"PMC_7981748","title":"Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9.","date":"1993","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7981748","citation_count":200,"is_preprint":false},{"pmid":"11781684","id":"PMC_11781684","title":"Identification of a nonsense mutation in the PAX9 gene in molar oligodontia.","date":"2001","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/11781684","citation_count":134,"is_preprint":false},{"pmid":"11827258","id":"PMC_11827258","title":"A novel mutation in human PAX9 causes molar oligodontia.","date":"2002","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/11827258","citation_count":126,"is_preprint":false},{"pmid":"15329380","id":"PMC_15329380","title":"MSX1, PAX9, and TGFA contribute to tooth agenesis in humans.","date":"2004","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/15329380","citation_count":125,"is_preprint":false},{"pmid":"11731698","id":"PMC_11731698","title":"Embryonic submandibular gland morphogenesis: stage-specific protein localization of FGFs, BMPs, Pax6 and Pax9 in normal mice and abnormal SMG phenotypes in FgfR2-IIIc(+/Delta), BMP7(-/-) and Pax6(-/-) mice.","date":"2002","source":"Cells, tissues, organs","url":"https://pubmed.ncbi.nlm.nih.gov/11731698","citation_count":118,"is_preprint":false},{"pmid":"21626677","id":"PMC_21626677","title":"Isolated oligodontia associated with mutations in EDARADD, AXIN2, MSX1, and PAX9 genes.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21626677","citation_count":117,"is_preprint":false},{"pmid":"20123092","id":"PMC_20123092","title":"Genetic interactions between Pax9 and Msx1 regulate lip development and several stages of tooth morphogenesis.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20123092","citation_count":115,"is_preprint":false},{"pmid":"11941488","id":"PMC_11941488","title":"Haploinsufficiency of PAX9 is associated with autosomal dominant hypodontia.","date":"2002","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11941488","citation_count":115,"is_preprint":false},{"pmid":"12490554","id":"PMC_12490554","title":"Pax1 and Pax9 activate Bapx1 to induce chondrogenic differentiation in the sclerotome.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12490554","citation_count":110,"is_preprint":false},{"pmid":"16651263","id":"PMC_16651263","title":"Functional consequences of interactions between Pax9 and Msx1 genes in normal and abnormal tooth development.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16651263","citation_count":101,"is_preprint":false},{"pmid":"12605438","id":"PMC_12605438","title":"Novel missense mutations and a 288-bp exonic insertion in PAX9 in families with autosomal dominant hypodontia.","date":"2003","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/12605438","citation_count":97,"is_preprint":false},{"pmid":"8812138","id":"PMC_8812138","title":"Expression of avian Pax1 and Pax9 is intrinsically regulated in the pharyngeal endoderm, but depends on environmental influences in the paraxial mesoderm.","date":"1996","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8812138","citation_count":93,"is_preprint":false},{"pmid":"10804168","id":"PMC_10804168","title":"Uncx4.1 is required for the formation of the pedicles and proximal ribs and acts upstream of Pax9.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10804168","citation_count":91,"is_preprint":false},{"pmid":"14571272","id":"PMC_14571272","title":"A missense mutation in PAX9 in a family with distinct phenotype of oligodontia.","date":"2003","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/14571272","citation_count":87,"is_preprint":false},{"pmid":"15615874","id":"PMC_15615874","title":"Novel mutation of the initiation codon of PAX9 causes oligodontia.","date":"2005","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/15615874","citation_count":85,"is_preprint":false},{"pmid":"24173808","id":"PMC_24173808","title":"Pax9 regulates a molecular network involving Bmp4, Fgf10, Shh signaling and the Osr2 transcription factor to control palate morphogenesis.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24173808","citation_count":84,"is_preprint":false},{"pmid":"16169709","id":"PMC_16169709","title":"Pax9 and Jagged1 act downstream of Gli3 in vertebrate limb development.","date":"2005","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/16169709","citation_count":81,"is_preprint":false},{"pmid":"12657635","id":"PMC_12657635","title":"Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12657635","citation_count":80,"is_preprint":false},{"pmid":"16236760","id":"PMC_16236760","title":"Reduction of Pax9 gene dosage in an allelic series of mouse mutants causes hypodontia and oligodontia.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16236760","citation_count":72,"is_preprint":false},{"pmid":"9541201","id":"PMC_9541201","title":"Pax genes and organogenesis: Pax9 meets tooth development.","date":"1998","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/9541201","citation_count":71,"is_preprint":false},{"pmid":"14689302","id":"PMC_14689302","title":"A novel missense mutation in the paired domain of PAX9 causes non-syndromic oligodontia.","date":"2003","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14689302","citation_count":66,"is_preprint":false},{"pmid":"8900176","id":"PMC_8900176","title":"Zebrafish Pax9 encodes two proteins with distinct C-terminal transactivating domains of different potency negatively regulated by adjacent N-terminal sequences.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8900176","citation_count":63,"is_preprint":false},{"pmid":"16479262","id":"PMC_16479262","title":"Molecular characterization of a novel PAX9 missense mutation causing posterior tooth agenesis.","date":"2006","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16479262","citation_count":61,"is_preprint":false},{"pmid":"28893947","id":"PMC_28893947","title":"Small-molecule Wnt agonists correct cleft palates in Pax9 mutant mice in utero.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28893947","citation_count":60,"is_preprint":false},{"pmid":"12786960","id":"PMC_12786960","title":"Novel mutation in the paired box sequence of PAX9 gene in a sporadic form of oligodontia.","date":"2003","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12786960","citation_count":60,"is_preprint":false},{"pmid":"11932925","id":"PMC_11932925","title":"Thymopoiesis requires Pax9 function in thymic epithelial cells.","date":"2002","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11932925","citation_count":58,"is_preprint":false},{"pmid":"28692808","id":"PMC_28692808","title":"Modulating Wnt Signaling Rescues Palate Morphogenesis in Pax9 Mutant Mice.","date":"2017","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/28692808","citation_count":56,"is_preprint":false},{"pmid":"17044090","id":"PMC_17044090","title":"New syndromic form of benign hereditary chorea is associated with a deletion of TITF-1 and PAX-9 contiguous genes.","date":"2006","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/17044090","citation_count":56,"is_preprint":false},{"pmid":"12115874","id":"PMC_12115874","title":"Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus.","date":"2002","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12115874","citation_count":55,"is_preprint":false},{"pmid":"10882524","id":"PMC_10882524","title":"Pax1/Pax9-Related genes in an agnathan vertebrate, Lampetra japonica: expression pattern of LjPax9 implies sequential evolutionary events toward the gnathostome body plan.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10882524","citation_count":55,"is_preprint":false},{"pmid":"28011632","id":"PMC_28011632","title":"A developmental transcriptomic analysis of Pax1 and Pax9 in embryonic intervertebral disc development.","date":"2017","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/28011632","citation_count":54,"is_preprint":false},{"pmid":"7647370","id":"PMC_7647370","title":"Differential expression of the chicken Pax-1 and Pax-9 gene: in situ hybridization and immunohistochemical analysis.","date":"1995","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/7647370","citation_count":51,"is_preprint":false},{"pmid":"16247549","id":"PMC_16247549","title":"PAX9 and TGFB3 are linked to susceptibility to nonsyndromic cleft lip with or without cleft palate in the Japanese: population-based and family-based candidate gene analyses.","date":"2005","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16247549","citation_count":50,"is_preprint":false},{"pmid":"28155232","id":"PMC_28155232","title":"PAX9 gene mutations and tooth agenesis: A review.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28155232","citation_count":49,"is_preprint":false},{"pmid":"15721141","id":"PMC_15721141","title":"Studies on Pax9-Msx1 protein interactions.","date":"2005","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/15721141","citation_count":47,"is_preprint":false},{"pmid":"25204874","id":"PMC_25204874","title":"G-quadruplex formation enhances splicing efficiency of PAX9 intron 1.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25204874","citation_count":47,"is_preprint":false},{"pmid":"14607846","id":"PMC_14607846","title":"Functional analysis of a mutation in PAX9 associated with familial tooth agenesis in humans.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14607846","citation_count":46,"is_preprint":false},{"pmid":"14504231","id":"PMC_14504231","title":"Identification of Cis-regulatory elements in the mouse Pax9/Nkx2-9 genomic region: implication for evolutionary conserved synteny.","date":"2003","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14504231","citation_count":46,"is_preprint":false},{"pmid":"8358169","id":"PMC_8358169","title":"A new Pax gene, Pax-9, maps to mouse chromosome 12.","date":"1993","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/8358169","citation_count":46,"is_preprint":false},{"pmid":"19279207","id":"PMC_19279207","title":"Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19279207","citation_count":45,"is_preprint":false},{"pmid":"15454262","id":"PMC_15454262","title":"Pax9 is required for filiform papilla development and suppresses skin-specific differentiation of the mammalian tongue epithelium.","date":"2004","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15454262","citation_count":45,"is_preprint":false},{"pmid":"16333316","id":"PMC_16333316","title":"A novel mutation in PAX9 causes familial form of molar oligodontia.","date":"2006","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16333316","citation_count":45,"is_preprint":false},{"pmid":"19429910","id":"PMC_19429910","title":"Pathogenic mechanisms of tooth agenesis linked to paired domain mutations in human PAX9.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19429910","citation_count":43,"is_preprint":false},{"pmid":"10204852","id":"PMC_10204852","title":"De novo deletion (14)(q11.2q13) including PAX9: clinical and molecular findings.","date":"1999","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10204852","citation_count":43,"is_preprint":false},{"pmid":"28910570","id":"PMC_28910570","title":"Nine Novel PAX9 Mutations and a Distinct Tooth Agenesis Genotype-Phenotype.","date":"2017","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/28910570","citation_count":41,"is_preprint":false},{"pmid":"21111400","id":"PMC_21111400","title":"PAX9 and MSX1 transcription factor genes in non-syndromic dental agenesis.","date":"2010","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/21111400","citation_count":41,"is_preprint":false},{"pmid":"18691704","id":"PMC_18691704","title":"Pbx1/Pbx2 govern axial skeletal development by controlling Polycomb and Hox in mesoderm and Pax1/Pax9 in sclerotome.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18691704","citation_count":38,"is_preprint":false},{"pmid":"21420399","id":"PMC_21420399","title":"Osr2 acts downstream of Pax9 and interacts with both Msx1 and Pax9 to pattern the tooth developmental field.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21420399","citation_count":37,"is_preprint":false},{"pmid":"29628999","id":"PMC_29628999","title":"A review on non-syndromic tooth agenesis associated with PAX9 mutations.","date":"2017","source":"The Japanese dental science review","url":"https://pubmed.ncbi.nlm.nih.gov/29628999","citation_count":36,"is_preprint":false},{"pmid":"16918677","id":"PMC_16918677","title":"Exclusion of coding region mutations in MSX1, PAX9 and AXIN2 in eight patients with severe oligodontia phenotype.","date":"2006","source":"Orthodontics & craniofacial research","url":"https://pubmed.ncbi.nlm.nih.gov/16918677","citation_count":36,"is_preprint":false},{"pmid":"29055049","id":"PMC_29055049","title":"PAX9 regulates squamous cell differentiation and carcinogenesis in the oro-oesophageal epithelium.","date":"2017","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29055049","citation_count":35,"is_preprint":false},{"pmid":"16585527","id":"PMC_16585527","title":"Natural selection and molecular evolution in primate PAX9 gene, a major determinant of tooth development.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16585527","citation_count":35,"is_preprint":false},{"pmid":"12833407","id":"PMC_12833407","title":"Aberrant Pax1 and Pax9 expression in Jarcho-Levin syndrome: report of two Caucasian siblings and literature review.","date":"2003","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/12833407","citation_count":33,"is_preprint":false},{"pmid":"10030590","id":"PMC_10030590","title":"Expression of the paired-box genes Pax-1 and Pax-9 in limb skeleton development.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10030590","citation_count":33,"is_preprint":false},{"pmid":"16137495","id":"PMC_16137495","title":"Association between PAX-9 promoter polymorphisms and hypodontia in humans.","date":"2005","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/16137495","citation_count":33,"is_preprint":false},{"pmid":"21530942","id":"PMC_21530942","title":"Sequence analysis of PAX9, MSX1 and AXIN2 genes in a Chinese oligodontia family.","date":"2011","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/21530942","citation_count":32,"is_preprint":false},{"pmid":"24436340","id":"PMC_24436340","title":"Novel PAX9 mutations cause non-syndromic tooth agenesis.","date":"2014","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/24436340","citation_count":32,"is_preprint":false},{"pmid":"26136503","id":"PMC_26136503","title":"Differentiation of Odontoblast-Like Cells From Mouse Induced Pluripotent Stem Cells by Pax9 and Bmp4 Transfection.","date":"2015","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26136503","citation_count":32,"is_preprint":false},{"pmid":"31444215","id":"PMC_31444215","title":"Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31444215","citation_count":32,"is_preprint":false},{"pmid":"21098475","id":"PMC_21098475","title":"Non-syndromic oligodontia with a novel mutation of PAX9.","date":"2010","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/21098475","citation_count":32,"is_preprint":false},{"pmid":"18028048","id":"PMC_18028048","title":"Identification of a novel mutation in the PAX9 gene in a family affected by oligodontia and other dental anomalies.","date":"2007","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18028048","citation_count":32,"is_preprint":false},{"pmid":"17697174","id":"PMC_17697174","title":"A novel nonsense mutation in PAX9 is associated with marked variability in number of missing teeth.","date":"2007","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17697174","citation_count":32,"is_preprint":false},{"pmid":"18653171","id":"PMC_18653171","title":"Tooth dimensions in hypodontia with a known PAX9 mutation.","date":"2008","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/18653171","citation_count":31,"is_preprint":false},{"pmid":"18701815","id":"PMC_18701815","title":"Identification and functional analysis of two novel PAX9 mutations.","date":"2008","source":"Cells, tissues, organs","url":"https://pubmed.ncbi.nlm.nih.gov/18701815","citation_count":30,"is_preprint":false},{"pmid":"17910065","id":"PMC_17910065","title":"A novel missense mutation in the paired domain of human PAX9 causes oligodontia.","date":"2007","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17910065","citation_count":30,"is_preprint":false},{"pmid":"30583699","id":"PMC_30583699","title":"The Function and Regulatory Network of Pax9 Gene in Palate Development.","date":"2018","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/30583699","citation_count":29,"is_preprint":false},{"pmid":"25299669","id":"PMC_25299669","title":"The formation of endoderm-derived taste sensory organs requires a Pax9-dependent expansion of embryonic taste bud progenitor cells.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25299669","citation_count":29,"is_preprint":false},{"pmid":"17097601","id":"PMC_17097601","title":"Temporal and spatial expression of Pax9 and Sonic hedgehog during development of normal mouse palates and cleft palates in TGF-beta3 null embryos.","date":"2006","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/17097601","citation_count":27,"is_preprint":false},{"pmid":"37159578","id":"PMC_37159578","title":"Tooth agenesis patterns and variants in PAX9: A systematic review.","date":"2023","source":"The Japanese dental science review","url":"https://pubmed.ncbi.nlm.nih.gov/37159578","citation_count":25,"is_preprint":false},{"pmid":"23227268","id":"PMC_23227268","title":"Novel PAX9 and COL1A2 missense mutations causing tooth agenesis and OI/DGI without skeletal abnormalities.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23227268","citation_count":24,"is_preprint":false},{"pmid":"23401059","id":"PMC_23401059","title":"Characterization of pax1, pax9, and uncx sclerotomal genes during Xenopus laevis embryogenesis.","date":"2013","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/23401059","citation_count":24,"is_preprint":false},{"pmid":"18395830","id":"PMC_18395830","title":"Function of Pax1 and Pax9 in the sclerotome of medaka fish.","date":"2008","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/18395830","citation_count":24,"is_preprint":false},{"pmid":"20618716","id":"PMC_20618716","title":"Mutations in the PAX9 gene in sporadic oligodontia.","date":"2010","source":"Orthodontics & craniofacial research","url":"https://pubmed.ncbi.nlm.nih.gov/20618716","citation_count":23,"is_preprint":false},{"pmid":"18979497","id":"PMC_18979497","title":"Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb.","date":"2008","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/18979497","citation_count":23,"is_preprint":false},{"pmid":"18353002","id":"PMC_18353002","title":"PAX9 polymorphisms and susceptibility to sporadic tooth agenesis: a case-control study in southeast China.","date":"2008","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18353002","citation_count":23,"is_preprint":false},{"pmid":"28040065","id":"PMC_28040065","title":"Effects of PAX9 and MSX1 gene variants to hypodontia, tooth size and the type of congenitally missing teeth.","date":"2016","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/28040065","citation_count":22,"is_preprint":false},{"pmid":"23921572","id":"PMC_23921572","title":"SNPs and interaction analyses of IRF6, MSX1 and PAX9 genes in patients with non‑syndromic cleft lip with or without palate.","date":"2013","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/23921572","citation_count":22,"is_preprint":false},{"pmid":"34341073","id":"PMC_34341073","title":"PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34341073","citation_count":21,"is_preprint":false},{"pmid":"26571067","id":"PMC_26571067","title":"A novel initiation codon mutation of PAX9 in a family with oligodontia.","date":"2015","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/26571067","citation_count":21,"is_preprint":false},{"pmid":"22277187","id":"PMC_22277187","title":"Novel missense mutations in PAX9 causing oligodontia.","date":"2012","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/22277187","citation_count":21,"is_preprint":false},{"pmid":"28813171","id":"PMC_28813171","title":"Anti-EDAR Agonist Antibody Therapy Resolves Palate Defects in Pax9-/- Mice.","date":"2017","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/28813171","citation_count":20,"is_preprint":false},{"pmid":"22747565","id":"PMC_22747565","title":"Novel missense mutation in PAX9 gene associated with familial tooth agenesis.","date":"2012","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22747565","citation_count":20,"is_preprint":false},{"pmid":"35533906","id":"PMC_35533906","title":"PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.","date":"2022","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/35533906","citation_count":19,"is_preprint":false},{"pmid":"20660504","id":"PMC_20660504","title":"Mutational analysis of MSX1 and PAX9 genes in Portuguese families with maxillary lateral incisor agenesis.","date":"2010","source":"European journal of orthodontics","url":"https://pubmed.ncbi.nlm.nih.gov/20660504","citation_count":18,"is_preprint":false},{"pmid":"16191360","id":"PMC_16191360","title":"[Novel mutations of PAX9 gene in Chinese patients with oligodontia].","date":"2005","source":"Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology","url":"https://pubmed.ncbi.nlm.nih.gov/16191360","citation_count":18,"is_preprint":false},{"pmid":"30809714","id":"PMC_30809714","title":"Familial oligodontia and regional odontodysplasia associated with a PAX9 initiation codon mutation.","date":"2019","source":"Clinical oral investigations","url":"https://pubmed.ncbi.nlm.nih.gov/30809714","citation_count":17,"is_preprint":false},{"pmid":"33078491","id":"PMC_33078491","title":"Functional study of novel PAX9 variants: The paired domain and non-syndromic oligodontia.","date":"2020","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33078491","citation_count":17,"is_preprint":false},{"pmid":"31069070","id":"PMC_31069070","title":"Genotyping analysis of the Pax9 Gene in patients with maxillary canine impaction.","date":"2019","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/31069070","citation_count":17,"is_preprint":false},{"pmid":"24028587","id":"PMC_24028587","title":"Novel PAX9 mutation associated with syndromic tooth agenesis.","date":"2013","source":"European journal of oral sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24028587","citation_count":17,"is_preprint":false},{"pmid":"35628401","id":"PMC_35628401","title":"PAX9 in Cancer Development.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35628401","citation_count":16,"is_preprint":false},{"pmid":"24222224","id":"PMC_24222224","title":"Mutational analysis of AXIN2, MSX1, and PAX9 in two Mexican oligodontia families.","date":"2013","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/24222224","citation_count":16,"is_preprint":false},{"pmid":"22976623","id":"PMC_22976623","title":"Association between PAX9 single-nucleotide polymorphisms and nonsyndromic cleft lip with or without cleft palate.","date":"2012","source":"The Journal of craniofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/22976623","citation_count":16,"is_preprint":false},{"pmid":"22058014","id":"PMC_22058014","title":"A novel nonsense mutation in PAX9 is associated with sporadic hypodontia.","date":"2011","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22058014","citation_count":16,"is_preprint":false},{"pmid":"32390226","id":"PMC_32390226","title":"Pax9's dual roles in modulating Wnt signaling during murine palatogenesis.","date":"2020","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/32390226","citation_count":15,"is_preprint":false},{"pmid":"11252173","id":"PMC_11252173","title":"Comparative analysis of the genomic organization of Pax9 and its conserved physical association with Nkx2-9 in the human, mouse, and pufferfish genomes.","date":"2001","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/11252173","citation_count":15,"is_preprint":false},{"pmid":"37005710","id":"PMC_37005710","title":"PAX9 mutations and genetic synergism in familial tooth agenesis.","date":"2023","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37005710","citation_count":14,"is_preprint":false},{"pmid":"31765609","id":"PMC_31765609","title":"Six2 regulates Pax9 expression, palatogenesis and craniofacial bone formation.","date":"2019","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/31765609","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47119,"output_tokens":8162,"usd":0.131893,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17535,"output_tokens":5777,"usd":0.11605,"stage2_stop_reason":"end_turn"},"total_usd":0.247943,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Pax9-deficient mice arrest tooth development at the bud stage and show loss of mesenchymal expression of Bmp4, Msx1, and Lef1, establishing Pax9 as required for the inductive capacity of the tooth mesenchyme.\",\n      \"method\": \"Targeted gene knockout (null allele) in mice; in situ hybridization for downstream markers\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype and downstream marker analysis, replicated across multiple subsequent studies\",\n      \"pmids\": [\"9732271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PAX9 protein binds to the e5 paired-domain recognition sequence from the Drosophila even-skipped promoter, demonstrating DNA-binding activity shared with PAX1.\",\n      \"method\": \"In vitro DNA-binding assay (gel shift / EMSA) with the e5 sequence\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro binding assay, single lab, single method\",\n      \"pmids\": [\"7649395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pax1 and Pax9 act redundantly to control vertebral column development: double homozygous mutant mice completely lack vertebral bodies, intervertebral discs and proximal ribs, with reduced cell proliferation in ventromedial sclerotomes and subsequent increased apoptosis; single Pax9 homozygous mutants show no axial defect, while Pax9 is spatially upregulated to compensate for Pax1 loss.\",\n      \"method\": \"Genetic epistasis using Pax1/Pax9 compound mutant mice; histology, BrdU proliferation assay, TUNEL apoptosis assay, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-mutant epistasis with multiple orthogonal readouts, replicated by subsequent studies\",\n      \"pmids\": [\"10556064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pax1 and Pax9 directly activate the Bapx1 promoter and physically interact with Bapx1 regulatory sequences; overexpression of Pax1 in chick presomitic mesoderm can substitute for Shh in inducing Bapx1 and initiating chondrogenic differentiation, establishing Bapx1 as a direct transcriptional target of Pax1/Pax9 downstream of Shh in sclerotome development.\",\n      \"method\": \"Pax1/Pax9 double-mutant analysis; retroviral Pax1 overexpression in chick explants; promoter-binding (transactivation assays and direct interaction with Bapx1 promoter region)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — transactivation assay + promoter binding + gain-of-function in explants, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12490554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PAX9 directly regulates Msx1 expression; PAX9 and MSX1 proteins physically interact and synergistically transactivate the Msx1 and Bmp4 promoters. A paired-domain missense mutation (L21P/T62C) abolishes DNA binding and promoter transactivation but retains protein-protein interaction with MSX1, indicating PAX9 regulates Bmp4 through its DNA-binding paired domain rather than solely through MSX1 protein interaction.\",\n      \"method\": \"Co-immunoprecipitation; luciferase reporter/transactivation assays with wild-type and mutant PAX9; DNA-binding assays (EMSA)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (co-IP, EMSA, reporter assay, mutagenesis) in a single rigorous study\",\n      \"pmids\": [\"16651263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pax9 and MSX1 proteins physically associate in vitro and in vivo (Co-IP and GST pull-down), consistent with a functional protein-protein interaction during tooth development.\",\n      \"method\": \"Co-immunoprecipitation and GST pull-down interaction assays\",\n      \"journal\": \"Archives of oral biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reciprocal Co-IP and GST pulldown, single lab\",\n      \"pmids\": [\"15721141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The 219InsG frameshift mutation in the PAX9 paired domain produces a protein with abolished DNA binding to e5 and CD19-2(A-ins) sequences and no transcriptional activation from paired-domain binding sites; the mutant protein also shows altered nuclear localization. Wild-type PAX9 transactivation is not impaired by co-expression of the mutant, indicating loss-of-function rather than dominant-negative mechanism.\",\n      \"method\": \"EMSA (gel mobility shift), co-transfection reporter assay, immunofluorescence localization, dominant-negative test in co-transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (EMSA, reporter, localization, dominant-negative test) in a single study\",\n      \"pmids\": [\"14607846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PLU-1 interacts with PAX9 (and BF-1) via a conserved VP motif; PAX9 represses transcription in reporter assays, and co-expression of PLU-1 with PAX9 significantly enhances this repression. Deletion or site-directed mutagenesis of the VP motif in PAX9 abolishes PLU-1 co-repressor activity, identifying PLU-1 as a transcriptional co-repressor of PAX9.\",\n      \"method\": \"Yeast two-hybrid screen; site-directed mutagenesis of VP motif; reporter (transcriptional repression) assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus mutagenesis plus reporter assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12657635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The R28P missense mutation in the N-terminal subdomain of the PAX9 paired domain dramatically reduces DNA binding to double-stranded paired-domain recognition sequences in vitro, supporting loss of DNA binding as the pathogenic mechanism for oligodontia.\",\n      \"method\": \"Gel mobility shift assay (EMSA) comparing wild-type and R28P mutant PAX9 paired domain binding to dsDNA targets\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro EMSA, single lab, single method\",\n      \"pmids\": [\"14689302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The Ile87Phe mutation in the C-terminal subdomain of the PAX9 paired domain abolishes DNA binding to e5 and CD19-2(A-ins) sequences but does not alter nuclear localization or protein-protein interaction with MSX1, demonstrating that DNA binding is selectively disrupted independent of partner protein interaction or trafficking.\",\n      \"method\": \"Gel shift assay (EMSA); cell fractionation/immunolocalization; co-immunoprecipitation with MSX1\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — EMSA + co-IP + localization, single lab\",\n      \"pmids\": [\"16479262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Structural and functional analysis of eight paired-domain missense mutations in PAX9 shows that most reduce DNA binding and transactivation of Bmp4 and Msx1 promoters correlating with disease severity; all mutants retain nuclear localization and physical interaction with MSX1; one mutant (retaining DNA binding) shows a dominant-negative effect and loss of synergism with MSX1 rather than loss of DNA binding.\",\n      \"method\": \"Subcellular localization (immunofluorescence), co-immunoprecipitation with MSX1, EMSA, luciferase reporter assays, structure-based modeling\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods across 8 mutations, single lab\",\n      \"pmids\": [\"19429910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Zebrafish Pax9 produces two splice isoforms (Pax9a and Pax9b) with distinct C-terminal transactivating domains of different potency; both activate transcription from a paired-domain binding site at low expression levels but show dose-dependent repression at higher amounts. The N-terminal region (including the paired domain) negatively regulates the C-terminal transactivation domains.\",\n      \"method\": \"Alternative splicing characterization; transactivation reporter assays with Pax9a and Pax9b expression vectors; paired-domain binding-site specificity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — reporter assay + splicing analysis, single lab\",\n      \"pmids\": [\"8900176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Genetic epistasis in Uncx4.1 mutant mice shows loss of pedicles and proximal ribs resembling the Pax1/Pax9 double-mutant phenotype, placing Uncx4.1 upstream of Pax9 in the caudolateral sclerotome developmental pathway.\",\n      \"method\": \"Targeted Uncx4.1 knockout mouse; comparison of skeletal phenotype with Pax1/Pax9 double mutants; histological and marker analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis by phenotypic comparison, single lab\",\n      \"pmids\": [\"10804168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Reduction of Pax9 gene dosage (hypomorphic and null allelic series in mice) causes oligodontia: homozygous hypomorphic mice show missing lower incisors and third molars, while compound hypomorphic/null mice develop severe oligodontia with dental arrest at different stages. Continuously growing incisors also exhibit enamel defects, establishing that a minimum Pax9 dosage is required throughout tooth development.\",\n      \"method\": \"Hypomorphic allele (Pax9neo) generation; compound allele analysis; histology of teeth at different developmental stages\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — allelic series with graded dosage effects, multiple tooth types and stages analyzed, single lab\",\n      \"pmids\": [\"16236760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Pax9 and Msx1 interact genetically in vivo: double homozygous mutants exhibit cleft lip; double heterozygous mutants consistently lack lower incisors with reduced Shh/Bmp2 expression defining a smaller incisor field, drastically reduced Fgf3/Fgf10 mesenchymal expression, reduced cell proliferation, and abnormal ameloblast differentiation. Transgenic BMP4 partially rescues the double-heterozygous incisor phenotype.\",\n      \"method\": \"Compound Pax9/Msx1 mutant mice; in situ hybridization for Shh, Bmp2, Fgf3, Fgf10, Notch1; BrdU proliferation assay; BMP4 transgenic rescue\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — compound mutant genetic epistasis with multiple orthogonal readouts and transgenic rescue, single lab\",\n      \"pmids\": [\"20123092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Osr2 acts downstream of Pax9 during tooth development: Osr2 mRNA is downregulated in Pax9-deficient tooth mesenchyme; Osr2 expression from the Pax9 locus (knock-in) rescues supernumerary tooth formation in Osr2-/- mutants; Osr2 forms a stable protein complex with MSX1 and interacts weakly with PAX9 in co-transfected cells.\",\n      \"method\": \"Pax9-conditional knockout with Osr2 knock-in (Pax9Osr2KI); co-immunoprecipitation of Osr2 with MSX1 and PAX9; in situ hybridization for Osr2, Bmp4, Msx1\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (knock-in rescue) plus co-IP protein interactions, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21420399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pax9 regulates palate development by controlling a molecular network: conditional deletion of Pax9 in palatal mesenchyme reduces Bmp4, Fgf10, Msx1, and Osr2 expression and disrupts Shh in palatal epithelium. Restoration of Osr2 expression from the Pax9 locus (Pax9Osr2KI knock-in) rescues posterior palate morphogenesis in the absence of Pax9 function, placing Osr2 downstream of Pax9 in this pathway.\",\n      \"method\": \"Tissue-specific Pax9 conditional knockout; Pax9Osr2KI knock-in rescue; in situ hybridization for Bmp4, Fgf10, Msx1, Osr2, Shh\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO plus knock-in rescue plus multiple downstream marker analysis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24173808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Pax9 regulates Wnt signaling during palatogenesis by suppressing expression of Dkk1 and Dkk2 (Wnt antagonists); ChIP-qPCR shows Pax9 directly binds to regions near the transcription start sites of Dkk1 and Dkk2 and to the intergenic region of Wnt9b/Wnt3. Genetic reduction of Dkk1 (or pharmacological Dkk inhibition) rescues secondary palate clefts in Pax9-/- mice, and genetic overexpression of Dkk1 phenocopies Pax9-/- palate and tooth defects.\",\n      \"method\": \"Genetic Dkk1 reduction/overexpression; small-molecule Dkk inhibitor delivery in utero; ChIP-qPCR for Pax9 binding to Dkk1, Dkk2, Wnt9b/Wnt3 loci\",\n      \"journal\": \"Development (Cambridge, England) / Developmental dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP-qPCR binding + genetic rescue + pharmacological rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"28893947\", \"32390226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Pax9-deficient mice show reduced canonical Wnt signaling in developing palatal mesenchyme (reduced Axin2, reduced active β-catenin, increased Dkk2); genetic inactivation of Wise (a secreted Wnt antagonist expressed in palatal shelves) in Pax9-deficient embryos rescues palatal shelf elevation/reorientation and restores hyaluronic acid accumulation, placing canonical Wnt signaling downstream of Pax9 in palate elevation.\",\n      \"method\": \"Pax9/Wise double-mutant genetic epistasis; immunohistochemistry for active β-catenin, Axin2, hyaluronic acid; in situ hybridization for Dkk2\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double-mutant genetic rescue with multiple molecular readouts, single lab\",\n      \"pmids\": [\"28692808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Pax9 is required for normal squamous cell differentiation in the oro-oesophageal epithelium: Pax9 deficiency in mouse oesophagus promotes cell proliferation and delays differentiation; ethanol exposure downregulates PAX9 in human oesophageal epithelial cells and mouse forestomach/tongue. PAX9 promoter hypermethylation is associated with silencing in human oro-oesophageal squamous cell carcinoma. PAX9 deficiency or ethanol promotes carcinogen-induced squamous cell carcinogenesis in mice.\",\n      \"method\": \"Conditional Pax9 knockout in mouse oesophagus; global gene expression profiling; ethanol exposure in vitro and in vivo; bisulfite sequencing for promoter methylation; carcinogen (NMBA) challenge model\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO phenotype + methylation + carcinogenesis model, single lab with multiple methods\",\n      \"pmids\": [\"29055049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pax9 is required in thymic epithelial cells for normal thymopoiesis: in Pax9 null mice, the thymic anlage forms as an ectopic polyp-like structure in the larynx expressing Foxn1/Whn, fails to migrate to the upper mediastinum, and is severely reduced in size by E14.5; TCRβ expression is detectable but TCRγ is absent.\",\n      \"method\": \"Pax9 null mouse analysis; immunohistochemistry and marker expression (Whn/Foxn1, TCRβ, TCRγ)\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean KO with defined cellular phenotype, single lab, single genetic model\",\n      \"pmids\": [\"11932925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Pax9 regulates region-specific differentiation of the tongue epithelium: in Pax9-deficient mice, filiform papillae lack anterior-posterior polarity (associated with altered Hoxc13 expression), barrier formation is disturbed, 'hard' keratins (Krt1-5, Krt1-24, Krt2-16) are not expressed, and 'soft' skin-specific keratins are upregulated, indicating partial trans-differentiation of tongue epithelium toward skin.\",\n      \"method\": \"Pax9 null mouse; genome-wide expression profiling; in situ hybridization for keratins and Hoxc13\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with genome-wide profiling and specific marker validation, single lab\",\n      \"pmids\": [\"15454262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pax9 expression in the anterior limb mesenchyme is dependent on Gli3 (repressor function) and is regulated by Shh-mediated Gli3 processing in a context-dependent manner: in Gli3Xt/Xt polydactylous mice, Pax9 is downregulated in anterior limb; Shh bead implantation in chick shows context-dependent Pax9 regulation differing between limb and somite.\",\n      \"method\": \"Gli3 null (Extra-toes) mouse transcriptional analysis; Shh/Gli3 compound mutant; Shh bead implantation in chick limb and somite\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic models and in vivo Shh signaling assay, single lab\",\n      \"pmids\": [\"16169709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pax9 acts upstream of Pax1 and Sox9 in the expanding taste progenitor field of the circumvallate papilla; Pax9-deficient mice completely fail to develop circumvallate papilla (arrest vs. partial reduction in Pax1 mutants). Pax9 is also required for Pax9-dependent induction of taste placodes in the soft palate but is dispensable for fungiform papilla taste bud development. Loss of Pax9 causes circumvallate taste progenitor cells to lack K8 and Prox1 expression and to differentiate into epidermal-like epithelium.\",\n      \"method\": \"Pax9 and Pax1 null mouse phenotypic comparison; genetic epistasis; immunofluorescence for K8, Prox1; in situ hybridization\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple orthogonal marker readouts, single lab\",\n      \"pmids\": [\"25299669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A G-quadruplex structure in PAX9 intron 1 (near exon 1) enhances splicing efficiency of PAX9 intron 1: mutation abolishing quadruplex formation dramatically decreases splicing efficiency in a reporter assay, and stabilization with the G-quadruplex ligand 360A further increases splicing efficiency.\",\n      \"method\": \"Circular dichroism (CD) spectroscopy; double-reporter splicing assay; qPCR; pharmacological G-quadruplex stabilization\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — biophysical structure confirmation + functional splicing assay + pharmacological validation, single lab\",\n      \"pmids\": [\"25204874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Pax9 is required in the pharyngeal endoderm for cardiovascular development; Pax9-deficient mice are born with complex cardiovascular malformations affecting the outflow tract and aortic arch arteries. Pax9 and Tbx1 genetically interact in the pharyngeal endoderm: double Tbx1+/-;Pax9+/- heterozygotes have significantly increased interrupted aortic arch incidence compared with Tbx1+/- alone. A Pax9Cre allele localizes the Tbx1-Pax9 interaction site to pharyngeal endoderm.\",\n      \"method\": \"Pax9 null mouse cardiovascular phenotyping; Tbx1/Pax9 double heterozygous mouse; Pax9Cre lineage tracing; transcriptome analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO phenotype + double-heterozygous epistasis + Cre-localization of interaction site, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"31444215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Pbx1/Pbx2 control Pax1/Pax9 expression in the sclerotome; in Pbx1/Pbx2 compound mutant mice, Pax1/Pax9 expression is downregulated in the sclerotome, and axial skeletal development is severely disrupted, placing Pbx1/Pbx2 genetically upstream of Pax1/Pax9 in the sclerotomal pathway.\",\n      \"method\": \"Pbx1/Pbx2 compound mutant mouse; marker analysis by in situ hybridization for Pax1, Pax9; skeletal phenotyping\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — compound mutant epistasis, single lab\",\n      \"pmids\": [\"18691704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PAX9 overexpression in dental pulp cells upregulates LEF1 and AXIN2 expression, indicating a positive regulatory role for PAX9 in canonical Wnt signaling; PAX9 missense mutations show differential loss of transcriptional activity and all overexpressed mutants except Pro118Ser show proper nuclear localization.\",\n      \"method\": \"PAX9 overexpression in dental pulp cells; RT-qPCR for LEF1 and AXIN2; immunofluorescence for subcellular localization; luciferase reporter assay\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — overexpression + reporter assay + localization, single lab\",\n      \"pmids\": [\"37005710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PAX9 occupies distal enhancer elements genome-wide in SCLC cells and represses nearby gene expression by restricting enhancer activity; PAX9 physically interacts and cofunctions with the NuRD (nucleosome remodeling and deacetylase) complex at enhancers. Genetic depletion of PAX9 induces a primed-to-active enhancer transition and upregulates neural differentiation and tumor-suppressive genes; pharmacological HDAC inhibition reverses PAX9/NuRD-mediated repression.\",\n      \"method\": \"Genome-wide CRISPR-Cas9 dropout screen; ChIP-seq for PAX9 occupancy; genome-wide enhancer state analysis (H3K4me1, H3K27ac); co-immunoprecipitation of PAX9 with NuRD complex; HDAC inhibitor treatment; RNA-seq after PAX9 depletion\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — genome-wide ChIP-seq + co-IP + CRISPR KO + pharmacological rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34341073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIX2 directly binds a PAX9 5' upstream regulatory element and activates PAX9 expression; a human SIX2 coding variant (p.Gly264Glu) found in a cleft palate patient destabilizes SIX2 protein and reduces PAX9 expression, placing SIX2 upstream of PAX9 in the palatogenesis regulatory network.\",\n      \"method\": \"SIX2 null mouse (22% cleft palate penetrance); ChIP/binding to PAX9 regulatory element; functional analysis of SIX2 p.Gly264Glu variant on PAX9 expression\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO phenotype + direct binding assay + human variant functional validation, single lab\",\n      \"pmids\": [\"31765609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Pax9 and c-myb function in the same pathway in oral squamous carcinoma cells: Pax9 knockdown induces apoptosis (caspase-3/PARP cleavage, increased Bax, decreased Bcl-2); c-myb overexpression upregulates Pax9; dominant-negative c-myb downregulates Pax9 without Pax9 affecting c-myb levels, placing c-myb upstream of Pax9 in cell survival regulation. Both Pax9 knockdown and dominant-negative c-myb arrest the cell cycle at G0.\",\n      \"method\": \"Pax9 siRNA knockdown; adenoviral c-myb overexpression and dominant-negative c-myb; flow cytometry (cell cycle); Western blot for caspase-3, PARP, Bax, Bcl-2\",\n      \"journal\": \"Cell biochemistry and function\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — siRNA KD + OE with multiple readouts, single lab\",\n      \"pmids\": [\"18979497\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAX9 is a paired-domain transcription factor that directly binds DNA recognition sequences and activates/represses target gene promoters (including Bmp4, Msx1, Lef1, Bapx1, Dkk1, Dkk2); it physically interacts with MSX1, OSR2, and PLU-1/NuRD complex to regulate transcription, acts upstream of Wnt (Dkk1/2 suppression), BMP, FGF, and SHH signaling cascades, and is essential—in a dose-dependent manner—for tooth morphogenesis (bud-to-cap transition), palatogenesis (mesenchyme-epithelium signaling via Osr2/Fgf10/Bmp4/Wnt), vertebral column chondrogenesis (redundantly with Pax1 through Bapx1), pharyngeal pouch organ (thymus, parathyroid) development, cardiovascular arch artery morphogenesis (via pharyngeal endoderm Tbx1 interaction), tongue epithelial differentiation, and circumvallate taste bud progenitor expansion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PAX9 is a paired-domain transcription factor that directs reciprocal mesenchymal-epithelial signaling during the development of teeth, palate, axial skeleton, pharyngeal organs, and taste-bearing epithelia [#0, #2]. Through its paired domain it binds defined recognition sequences (e.g., the e5 site) and transactivates target promoters, with disease-associated missense and frameshift mutations selectively abolishing DNA binding and transactivation of Bmp4 and Msx1 while sparing nuclear localization and protein partner interaction, establishing loss of DNA binding as the predominant pathogenic mechanism in PAX9-associated oligodontia [#1, #6, #10]. In tooth and palate mesenchyme PAX9 sustains an inductive program—activating Bmp4, Msx1, Fgf3/Fgf10, and Osr2—and acts in part by physically associating with and synergizing with MSX1 on the Msx1 and Bmp4 promoters [#0, #4, #14, #16]; Osr2 lies genetically downstream, as Osr2 knocked into the Pax9 locus rescues Pax9-dependent palate morphogenesis [#15, #16]. PAX9 also gates Wnt signaling during palatogenesis, directly binding and repressing the Wnt antagonists Dkk1 and Dkk2 so that reducing Dkk1 or Wise rescues Pax9-null palatal clefts [#17, #18]. In the axial skeleton PAX9 functions redundantly with PAX1 to drive sclerotome chondrogenesis through direct activation of the Bapx1 promoter downstream of Shh [#2, #3], and it is further required in pharyngeal endoderm for cardiovascular outflow morphogenesis via genetic interaction with Tbx1 [#25] and for thymic epithelial development [#20]. Beyond development, PAX9 can act as a context-dependent transcriptional repressor: it recruits the PLU-1/NuRD complex through a conserved VP motif [#7] and occupies distal enhancers genome-wide in small-cell lung cancer cells to restrict enhancer activity and suppress differentiation genes [#28].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established that PAX9 is a sequence-specific DNA-binding protein, defining the biochemical basis for its later-discovered transcriptional roles.\",\n      \"evidence\": \"In vitro EMSA with the Drosophila even-skipped e5 paired-domain recognition site\",\n      \"pmids\": [\"7649395\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No endogenous mammalian target identified at this stage\", \"Activator vs. repressor function not resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolved that PAX9 transactivation is dose- and isoform-dependent, with the N-terminal/paired region negatively regulating C-terminal activation domains.\",\n      \"evidence\": \"Zebrafish Pax9a/Pax9b splice isoform reporter assays with paired-domain binding sites\",\n      \"pmids\": [\"8900176\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional relevance of dual isoforms in mammals unknown\", \"Switch between activation and repression not mechanistically defined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated that Pax9 is required for the inductive capacity of tooth mesenchyme, placing it at the top of an odontogenic signaling cascade.\",\n      \"evidence\": \"Pax9 null mouse with in situ analysis of Bmp4, Msx1, Lef1 at the tooth bud stage\",\n      \"pmids\": [\"9732271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Bmp4/Msx1/Lef1 are direct vs. indirect targets not shown\", \"Cell-autonomous mechanism within mesenchyme not dissected\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Revealed functional redundancy between Pax1 and Pax9 in vertebral column formation, explaining the absence of axial defects in single Pax9 mutants.\",\n      \"evidence\": \"Pax1/Pax9 compound mutant mice with histology, BrdU, TUNEL, in situ hybridization\",\n      \"pmids\": [\"10556064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Shared vs. distinct downstream targets not defined here\", \"Molecular basis of Pax9 compensatory upregulation unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Positioned Uncx4.1 upstream of Pax9 in the caudolateral sclerotome pathway, beginning to assemble the regulatory hierarchy controlling axial Pax9 expression.\",\n      \"evidence\": \"Uncx4.1 knockout mouse skeletal phenotype compared with Pax1/Pax9 double mutants\",\n      \"pmids\": [\"10804168\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect regulation of Pax9 not established\", \"No biochemical link demonstrated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified Bapx1 as a direct Pax1/Pax9 transcriptional target downstream of Shh, connecting Pax9 to sclerotome chondrogenic differentiation.\",\n      \"evidence\": \"Promoter transactivation/binding assays plus retroviral Pax1 gain-of-function in chick presomitic mesoderm\",\n      \"pmids\": [\"12490554\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Pax9 (vs. Pax1) binding to Bapx1 not separately quantified\", \"Cofactor requirements at the promoter not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined PLU-1 as a VP-motif-dependent co-repressor of PAX9, revealing that PAX9 can actively repress transcription.\",\n      \"evidence\": \"Yeast two-hybrid, VP-motif mutagenesis, and repression reporter assays\",\n      \"pmids\": [\"12657635\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous PAX9-repressed genes not identified\", \"In vivo relevance of PLU-1 interaction untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that oligodontia-causing PAX9 paired-domain mutations (219InsG, R28P) abolish DNA binding via loss-of-function rather than dominant-negative mechanism.\",\n      \"evidence\": \"EMSA, reporter assays, immunofluorescence localization, and co-transfection dominant-negative tests of mutant PAX9\",\n      \"pmids\": [\"14607846\", \"14689302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype severity correlation not yet mapped\", \"Effect on partner protein function not assessed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed that a minimum Pax9 gene dosage is required throughout tooth development, linking quantitative Pax9 levels to graded oligodontia severity.\",\n      \"evidence\": \"Hypomorphic/null allelic series in mice with staged tooth histology\",\n      \"pmids\": [\"16236760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dosage-sensitive target genes not defined\", \"Threshold mechanism at the molecular level unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Documented direct physical association of PAX9 with MSX1, providing a protein-interaction basis for combinatorial regulation in tooth development.\",\n      \"evidence\": \"Reciprocal Co-IP and GST pull-down assays\",\n      \"pmids\": [\"15721141\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interaction interface not mapped\", \"Functional consequence on transcription not tested in this study\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated that PAX9 and MSX1 synergistically transactivate Msx1 and Bmp4 promoters and that PAX9 regulates Bmp4 through its DNA-binding paired domain, separating DNA-binding from protein-interaction functions.\",\n      \"evidence\": \"Co-IP, EMSA, luciferase reporter assays with wild-type and DNA-binding-deficient mutant PAX9; analysis of the Ile87Phe mutation\",\n      \"pmids\": [\"16651263\", \"16479262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structure of the PAX9-MSX1-DNA complex unknown\", \"Other partner-dependent target genes not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Correlated paired-domain mutation effects on DNA binding and transactivation with oligodontia severity and identified a rare dominant-negative mutant acting through loss of MSX1 synergy.\",\n      \"evidence\": \"Structure-based modeling, EMSA, reporter assays, Co-IP and localization across eight missense mutants\",\n      \"pmids\": [\"19429910\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution PAX9-DNA structure not solved\", \"Mechanism of dominant-negative interference not fully defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established in vivo genetic interaction between Pax9 and Msx1 in incisor and lip development, with BMP4 acting downstream as a partial mediator.\",\n      \"evidence\": \"Compound Pax9/Msx1 mutant mice with marker in situ, BrdU assays, and BMP4 transgenic rescue\",\n      \"pmids\": [\"20123092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect control of Fgf3/Fgf10 not resolved\", \"Incomplete rescue indicates additional unidentified effectors\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed Osr2 downstream of Pax9 in tooth development, with Osr2 knock-in rescuing supernumerary tooth phenotypes.\",\n      \"evidence\": \"Pax9-conditional knockout with Pax9-locus Osr2 knock-in; Co-IP of Osr2 with MSX1 and PAX9\",\n      \"pmids\": [\"21420399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Pax9 directly binds the Osr2 promoter not shown\", \"Weak PAX9-Osr2 interaction functional role unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined Pax9 as the controller of a Bmp4/Fgf10/Msx1/Osr2/Shh network in palatal mesenchyme, with Osr2 sufficient to rescue posterior palate morphogenesis.\",\n      \"evidence\": \"Tissue-specific Pax9 conditional knockout and Pax9-locus Osr2 knock-in with downstream marker in situ hybridization\",\n      \"pmids\": [\"24173808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PAX9 binding to these promoters in palate not all demonstrated\", \"Anterior vs. posterior palate mechanistic differences not fully resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified direct PAX9 repression of Wnt antagonists Dkk1/Dkk2 as the mechanism linking Pax9 to canonical Wnt signaling in palatogenesis, validated by genetic and pharmacological rescue.\",\n      \"evidence\": \"ChIP-qPCR for Pax9 at Dkk1/Dkk2/Wnt loci; genetic Dkk1 reduction/overexpression; in utero Dkk inhibitor; Pax9/Wise double-mutant rescue with β-catenin/Axin2 readouts\",\n      \"pmids\": [\"28893947\", \"32390226\", \"28692808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect contribution of Wnt9b/Wnt3 binding unclear\", \"Tissue-specific cofactors for repression not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended Pax9 function to squamous epithelial differentiation, showing it restrains proliferation and that its silencing (including by ethanol and promoter hypermethylation) promotes squamous carcinogenesis.\",\n      \"evidence\": \"Conditional Pax9 knockout in mouse oesophagus, expression profiling, ethanol exposure, bisulfite sequencing, NMBA carcinogen model\",\n      \"pmids\": [\"29055049\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional targets in epithelium not defined\", \"Mechanism connecting PAX9 loss to carcinogenesis incomplete\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated a pharyngeal-endoderm requirement for Pax9 in cardiovascular development through genetic interaction with Tbx1.\",\n      \"evidence\": \"Pax9 null cardiovascular phenotyping, Tbx1/Pax9 double-heterozygous epistasis, Pax9Cre lineage tracing, transcriptomics\",\n      \"pmids\": [\"31444215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical Pax9-Tbx1 relationship not shown\", \"Endodermal target genes mediating arch artery defects not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Positioned SIX2 as a direct upstream activator of PAX9 in palatogenesis, with a human SIX2 variant reducing PAX9 expression.\",\n      \"evidence\": \"SIX2 null mouse, ChIP/binding to PAX9 regulatory element, functional analysis of SIX2 p.Gly264Glu\",\n      \"pmids\": [\"31765609\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Other upstream regulators of PAX9 in palate not mapped\", \"Quantitative contribution of SIX2 to PAX9 dosage unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed a genome-wide enhancer-repression mechanism in which PAX9 cofunctions with the NuRD complex to restrict differentiation and tumor-suppressor gene activity in SCLC.\",\n      \"evidence\": \"CRISPR dropout screen, PAX9 ChIP-seq, enhancer-state profiling, PAX9-NuRD Co-IP, HDAC inhibitor rescue, RNA-seq after depletion\",\n      \"pmids\": [\"34341073\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DNA sequence determinants of enhancer occupancy not defined\", \"Generalizability beyond SCLC unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how PAX9 switches between activator and repressor modes across tissues and how cofactor choice (MSX1, OSR2, PLU-1/NuRD) is determined at specific loci.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of PAX9 bound to DNA with cofactors\", \"Mechanism selecting activation vs. repression context not resolved\", \"Full genome-wide target catalog in developmental tissues lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 4, 6, 8, 9, 10, 28]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 4, 7, 11, 17, 28]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [4, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 9, 10, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 2, 16, 23, 25]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 17, 28]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 17, 18]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"complexes\": [\"NuRD complex\"],\n    \"partners\": [\"MSX1\", \"OSR2\", \"PLU-1\", \"TBX1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}